CSIMarket Company Name, Ticker, Customers, else..
 
Icecure Medical Ltd  (NASDAQ: ICCM)
 
Price: $2.1200 $-0.02 -0.935%
Day's High: $2.2200000286102295 Week Perf: -4.93 %
Day's Low: $ 2.10 30 Day Perf: -31.72 %
Volume (M): 32,873 52 Wk High: $ 42.00
Volume (M$): $ 0 52 Wk Avg: $14.11
Open: $2.18 52 Wk Low: $2.06



 Market Capitalization (Millions $) 4
 Shares Outstanding (Millions) 2
 Employees 55
 Revenues (TTM) (Millions $) 3
 Net Income (TTM) (Millions $) 15
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

Business Description


Icecure Medical Ltd is a medical technology company that specializes in developing and commercializing innovative cryoablation systems. Their flagship product, ProSense, is a non-invasive procedure that uses extreme cold to ablate tumors and other diseased tissue in a variety of medical applications. Icecure's cryoablation technology offers a safe and effective alternative to traditional surgery or radiation therapy. The company is based in Israel and is dedicated to improving patient outcomes and revolutionizing the field of minimally invasive medicine.


   Company Address: 7 Ha’Eshel St Caesarea 3079504
   Company Phone Number: 4.6230333   Stock Exchange / Ticker: NASDAQ ICCM


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
BDX   -6.1%    
BSX   -7.83%    
EW   -5.11%    
MDT   -2.35%    
SYK   -12.49%    
ZBH   -6.52%    
• View Complete Report
   



Products & Services

Revolutionary Breakthrough in Extra-Pelvis Endometriosis Treatment Unleashes Hope for Millions

Published Mon, Mar 4 2024 1:30 PM UTC

IceCure Medical Ltd., an Israeli medical technology company, has recently unveiled a groundbreaking treatment for extra-pelvis endometriosis. The promising alternative solution, known as ProSense, has shown remarkable efficacy in an independent study, according to research presented at the European Congress of Radiology in 2024.Endometriosis is a debilitating condition affec...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) 0.29
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 1.33
Price to Sales (Expected) -
Price to Book 0.5
PEG (TTM) -

Financial Strength Current
Quick Ratio 3.9
Working Capital Ratio 4.14
Leverage Ratio (MRQ) 0.25
Total Debt to Equity 0
Interest Coverage (TTM) -
Debt Coverage (TTM) 29.13

Per Share Current
Earnings (TTM) 7.2 $
Revenues (TTM) 1.59 $
Cash Flow (TTM) -
Cash 4.2 $
Book Value 4.27 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 61,436
Net Income per Employee (TTM) 273,764
Receivable Turnover Ratio (TTM) 17.17
Inventory Turnover Ratio (TTM) 1.06
Asset Turnover Ratio (TTM) 0.18

Profitability Ratios Current
Gross Margin (MRQ) 36.28 %
Operating Margin (MRQ) 446.7 %
Net Margin (MRQ) 445.61 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) 78.5 %
Return On Investment (TTM) 197.84 %
Return On Equity (TTM) 200.47 %
Dividend Yield -
Pay out Ratio (TTM) -



Icecure Medical Ltd's Segments





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.